Results 71 to 80 of about 6,016 (111)

肝癌细胞株SMMC-7721中CD147和MMP-9的表达及意义

open access: yesZhongguo shiyan zhenduanxue, 2008
目的研究肝癌细胞系SMMC-7721中CD147与基质金属蛋白酶-9(MMP-9)的表达及意义。方法用流式细胞仪检测正常肝细胞L-02与肝癌细胞SMMC-7221中CD147的表达;用免疫组化法检测两种细胞产生的MMP-9的表达。结果正常肝细胞L-02中CD147表达阴性,SMMC-7721中CD147表达呈强阳性(阳性率为98.1%);MMP-9在正常肝细胞及肝癌细胞中均有表达,但在肝癌细胞中表达明显增高。结论肝癌细胞系SMMC-7721中CD147与MMP-9表达明显增高,与肝癌的侵袭转移潜能有关。
宫路路   +4 more
doaj  

[Research progress in liver cancer in 2025]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Miao TG, Nan YM.
europepmc   +1 more source

[Interferon-α induces disulfidptosis occurrence in human liver cancer cells]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Bi XY   +5 more
europepmc   +1 more source

[Progress and application of liver organoids in the study of liver cancer]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi, 2023
Wang M   +5 more
europepmc   +1 more source

原发性肝癌术后复发的再次外科治疗

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 1992
1980~1990年,作者收治原发性肝癌660例,手术切除124例(18.8%)。术后肝内复发者32例(肝内复发率25.8%),2 年以内复发者占93.8%。93.7%合并肝硬化,15.5%并发门脉高压症。复发肝癌中4例(3.2%,4/124)行再切除,术后生存平均26.8月;22例行B超引导肝癌复发灶无水酒精注射术,术后8例死亡,平均生存8.5月;10例行肝动脉栓塞化疗或肝动脉结扎及插管化疗,术后生存平均16.8月,对照组仅4.5月。复发癌再次外科治疗以再切除术为首选(术后生存26.8~42.6月 ...
doaj  

[The value of the nutritional assessment index or score in prognostic evaluation for patients with liver cancer]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Shen JC   +5 more
europepmc   +1 more source

[Strategies for immunotherapy-related hepatotoxicity in liver cancer]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi, 2023
Zhi Y, Mao YM.
europepmc   +1 more source

[ERI3 expression is elevated in hepatocellular carcinoma and correlates with poor patient prognosis]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Zhao X   +8 more
europepmc   +1 more source

[HDAC2-mediated H3K27 acetylation promotes the proliferation and migration of hepatocellular carcinoma cells]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Tang S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy